RxDoctor Payments Data

Wilson Movic

Optometrist · Bloomington, ILNPI 1194730648

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (36.8%), travel and lodging and speaking fees — rather than concentrated in one kind of arrangement. Alcon accounts for 88.4% of it on its own, with 16 other manufacturers making up the rest. Reporting peaked in 2019 at $27,849 and has fallen 96.8% since, to $881 in 2025. Among optometrist clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$90,715in general payments, 2019–2025

Across 379 payments — averaging $239.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alcon$80K
  • Johnson & Johnson Vision Care, Inc.$6K
  • Bausch & Lomb, A Division Of Bausch Health US, LLC$2K
  • Bausch & Lomb Americas Inc.$544
  • Novartis$270
  • Mallinckrodt Hospital Products Inc.$245
  • plus $1K from 11 others
$917,306in research payments, 2019–2025

Across 791 payments — averaging $1159.68 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Alcon Research LLC$461K
  • Johnson & Johnson Vision Care, Inc.$364K
  • Bausch Health US, LLC$93K

What the payments were for

  • Consulting fees$33,40037%
  • Speaking & faculty fees$22,44325%
  • Travel & lodging$28,02031%
  • Food & beverage$6,8538%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$90,715 in reported general payments places this provider in the 95th percentile of 2,257 optometrist providers in Illinois.

See all optometrist providers in Illinois

Medicare billing

Part B allowed, 2024
$39,437
Medicare patients
253
Services billed
455

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Tobramycin-DexamethasoneTobramycin/Dexamethasone12$654
Latanoprost32$366
Azithromycin13$53
Timolol Maleate12$26

Paid to pharmacies, not to this prescriber.

Other optometrist in Bloomington

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →